To you, it's just a ride-sharing app that gets you where you're going. But to an economist, Uber is a massive repository of moment-by-moment data that is helping answer some of the field's most elusive questions.

The gist: we spend billions on end-of-life healthcare that doesn’t do much good. So what if a patient could forego the standard treatment and get a cash rebate instead?